Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin
- PMID: 2877505
Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin
Abstract
Treatment with total parenteral nutrition (TPN) alone or combined with continuous intravenous infusion of either somatostatin or calcitonin or glucagon have been carried out upon 45 patients with a high output external pancreatic fistula. No significant difference among these treatment schedules was observed in the percentage of closure of fistulas (85 to 100 per cent of the patients), but patients treated with TPN plus somatostatin had the fistulas close within a significantly (p = 0.000028) shorter period of time. Moreover, this treatment was associated with the strongest inhibition of the output from the fistula (minus 82.3 per cent). Since treatment with somatostatin was not accompanied by any side effect, was followed by a quite rapid closure of the fistulas and allowed an estimated economic savings of about $2,100.00 dollars per patient, it seems to be advisable in the conservative treatment of external pancreatic fistulas.
Similar articles
-
[Use of somatostatin in the conservative treatment of external pancreatic fistula].Rev Esp Enferm Apar Dig. 1989 Sep;76(3):222-8. Rev Esp Enferm Apar Dig. 1989. PMID: 2573114 Clinical Trial. Spanish.
-
Treatment of enterocutaneous fistulas with TPN and somatostatin, compared with patients who received TPN only.Br J Clin Pract. 1990 Dec;44(12):616-8. Br J Clin Pract. 1990. PMID: 1983231 Clinical Trial.
-
[Medical treatment of external pancreatic fistulas: total parenteral nutrition, somatostatin, terbutaline].Gastroenterol Clin Biol. 1985 Dec;9(12):952. Gastroenterol Clin Biol. 1985. PMID: 2870002 French. No abstract available.
-
Somatostatin treatment of gastrointestinal fistulae.Ann Chir Gynaecol. 1989;78(2):124-6. Ann Chir Gynaecol. 1989. PMID: 2572196 Review.
-
Somatostatin analogues and pancreatic fistulas.Digestion. 1996;57 Suppl 1:94-6. doi: 10.1159/000201409. Digestion. 1996. PMID: 8813483 Review.
Cited by
-
Preventive effects of ulinastatin on complications related to pancreaticoduodenectomy: A Consort-prospective, randomized, double-blind, placebo-controlled trial.Medicine (Baltimore). 2016 Jun;95(24):e3731. doi: 10.1097/MD.0000000000003731. Medicine (Baltimore). 2016. PMID: 27310952 Free PMC article. Clinical Trial.
-
Pancreatic trauma: diagnostic and therapeutic strategies.Curr Treat Options Gastroenterol. 2005 Oct;8(5):355-63. doi: 10.1007/s11938-005-0038-4. Curr Treat Options Gastroenterol. 2005. PMID: 16162301
-
Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data.Gut. 2001 Dec;49 Suppl 4(Suppl 4):iv11-21. doi: 10.1136/gut.49.suppl_4.iv11. Gut. 2001. PMID: 11878789 Free PMC article. Review.
-
Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.Drugs. 1989 Nov;38(5):658-702. doi: 10.2165/00003495-198938050-00002. Drugs. 1989. PMID: 2689136 Review.
-
The relevance of gastrointestinal fistulae in clinical practice: a review.Gut. 2001 Dec;49 Suppl 4(Suppl 4):iv2-10. doi: 10.1136/gut.49.suppl_4.iv2. Gut. 2001. PMID: 11878790 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Research Materials